文献速递炎症性肠病

MFGE8可预防肠道纤维化

Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis.
PubMed 文献 · Gut · 2024-06-06

该研究通过脱细胞全层肠道组织平台分析纤维狭窄型克罗恩病(CD)的细胞外基质(ECM)组成,发现狭窄组织中MFGE8表达升高;MFGE8可抑制正常对照来源的人肠道肌成纤维细胞(HIMF)产生ECM,并预防及逆转实验性肠道纤维化,机制涉及整合素αvβ5及黏着斑激酶信号通路。

要点

  • 纤维狭窄型CD组织中MFGE8在mRNA和蛋白水平均升高
  • MFGE8抑制正常HIMF的ECM产生,但对CDs HIMF无此作用
  • MFGE8通过整合素αvβ5/FAK通路发挥抗纤维化效应

核心结论

  • MFGE8具有抗纤维化作用,未来可能用于预防IBD所致肠道狭窄。

研究设计与样本

  • 研究建立并验证了肠道IBD组织的最佳脱细胞方案,并用蛋白质组学探索不同组织表型的ECM组成,再以qPCR和免疫组化验证。
  • 研究用MFGE8处理原代人肠道肌成纤维细胞(HIMF)评估抗纤维化机制,并在两种实验性肠道纤维化模型中测试MFGE8的作用。

主要发现

  • Matrisome分析显示纤维狭窄型CD(CDs)组织中MFGE8表达升高,并在mRNA和蛋白水平得到确认。
  • MFGE8处理抑制正常对照HIMF的ECM产生,但不抑制CDs HIMF的ECM产生。
  • 下一代测序揭示整合素介导的信号通路具有功能相关性,阻断整合素αvβ5和黏着斑激酶使HIMF对MFGE8无反应。
  • MFGE8在体外和体内均可预防并逆转实验性肠道纤维化。

临床怎么用

  • MFGE8给药可能成为未来预防IBD诱导肠道狭窄的候选策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intestinal fibrosis is considered an inevitable consequence of chronic IBD, leading to stricture formation and need for surgery. During the process of fibrogenesis, extracellular matrix (ECM) components critically regulate the function of mesenchymal cells. We characterised the composition and function of ECM in fibrostenosing Crohn's disease (CD) and control tissues. DESIGN: Decellularised full-thickness intestinal tissue platforms were tested using three different protocols, and ECM composition in different tissue phenotypes was explored by proteomics and validated by quantitative PCR (qPCR) and immunohistochemistry. Primary human intestinal myofibroblasts (HIMFs) treated with milk fat globule-epidermal growth factor 8 (MFGE8) were evaluated regarding the mechanism of their antifibrotic response, and the action of MFGE8 was tested in two experimental intestinal fibrosis models. RESULTS: We established and validated an optimal decellularisation protocol for intestinal IBD tissues. Matrisome analysis revealed elevated MFGE8 expression in CD strictured (CDs) tissue, which was confirmed at the mRNA and protein levels. Treatment with MFGE8 inhibited ECM production in normal control HIMF but not CDs HIMF. Next-generation sequencing uncovered functionally relevant integrin-mediated signalling pathways, and blockade of integrin αvβ5 and focal adhesion kinase rendered HIMF non-responsive to MFGE8. MFGE8 prevented and reversed experimental intestinal fibrosis in vitro and in vivo. CONCLUSION: MFGE8 displays antifibrotic effects, and its administration may represent a future approach for prevention of IBD-induced intestinal strictures.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Lin S, Wang J, Mukherjee PK, et al. Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis. Gut. 2024. PMID: 38378253. doi:10.1136/gutjnl-2022-328608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。